Plant-based clinical nutrition company, Kate Farms, has raised $75 million in a Series C funding round.
Kate Farms produces organic and vegan-friendly formulas for tube and oral feeding to meet the nutritional needs of those with chronic illnesses and acute conditions.
Led by life science investor Novo Holdings, the round also received participation from existing investors, and is for a minority stake in the company.
“Novo Holdings’ investment in Kate Farms will allow us to develop more innovative products, enter new markets and continue to serve the patients who depend on us for their nutrition, as well as thousands of healthcare providers,” said Kate Farms chairman and CEO, Brett Matthews.
Kartik Dharmadhikari, partner, Novo Growth, Novo Holdings, added: “We are pleased to partner with Kate Farms and support them in their efforts to meet the nutritional needs of numerous patient populations”.
“We believe our life sciences heritage can serve the company well as it explores additional ways to utilise science and clinical evidence to support plant-based clinical nutrition.”
© FoodBev Media Ltd 2024
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry. Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial
Your privacy We use small files known as ‘cookies’ to enhance your experience of the FoodBev website and analyse site-traffic. Read about how we use cookies or how you may control them in our updated privacy policy and cookie policy. If you continue to use this site, you consent to our use of cookies. Click the ‘OKAY‘ button at the top right of this panel to accept or click here for more information.